Source:http://linkedlifedata.com/resource/pubmed/id/15199335
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
6
|
| pubmed:dateCreated |
2004-6-16
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jun
|
| pubmed:issn |
1097-6744
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:volume |
147
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
939-41
|
| pubmed:dateRevised |
2007-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:15199335-Adult,
pubmed-meshheading:15199335-Anticholesteremic Agents,
pubmed-meshheading:15199335-Apolipoprotein A-I,
pubmed-meshheading:15199335-Cholesterol, HDL,
pubmed-meshheading:15199335-Coronary Artery Disease,
pubmed-meshheading:15199335-Female,
pubmed-meshheading:15199335-Humans,
pubmed-meshheading:15199335-Male
|
| pubmed:year |
2004
|
| pubmed:articleTitle |
High-density lipoprotein cholesterol as a therapeutic target to reduce cardiovascular events.
|
| pubmed:publicationType |
Editorial,
Comment
|